HOME >> MEDICINE >> NEWS
Most household cleaners remove peanut allergens, Hopkins study shows

m a clean table. All cleaning techniques except dishwashing soap removed the allergen; dish soap left residual Ara h 1 on 4 of 12 samples.

The Hopkins researchers sampled various surfaces in six schools and preschools in the Baltimore area, and found traces of allergen on only 1 of 13 water fountains, and on none of 22 desks or 36 cafeteria tables.

In an effort to simulate and measure potential airborne allergen exposure at schools and sporting events, and on airplanes, the investigators asked the 19 volunteers to eat peanut butter sandwiches, roasted whole peanuts in their shells and shelled peanuts while wearing small air monitors to study the amount of inhaled allergen. They also were asked to discard peanut shells on the floor and walk on them, and open 15 bags of unshelled peanuts and eat them.

The investigators failed to detect Ara h 1 in any of these settings, though Wood cautions that the team's measuring techniques might not have been sensitive enough to find small amounts of allergen. "Future studies that include challenging patients with peanut allergy in these settings will be needed to more reliably assess the risks of airborne exposures," he says.

Peanut allergy is the third most common food allergy in young children and the most common food allergy in older children, adolescents and adults.


'"/>

Contact: Staci Vernick
svernick@jhmi.edu
410-516-4958
Johns Hopkins Medical Institutions
8-May-2004


Page: 1 2

Related medicine news :

1. Direct payments to households in poor countries could improve maternal & child health
2. New technique uses household humidifier to create nanocomposite materials
3. Fossil fuels for household use are viable option for worlds poor
4. Under one roof: The risks associated with living in three-generation households
5. Training could remove racial bias from police reactions
6. Hyperactive kids three times as likely to be removed from their families
7. Mouse shows how Rituximab removes human B cells
8. Screening removes West Nile from bood supply
9. Purefecta (TM) drinking water purifier from Pall and Kinetico removes pathogens...
10. Treating eye pain may remove other migraine symptoms
11. Outgrown a peanut allergy? Eat more peanuts!

Post Your Comments:
(Date:6/29/2015)... CA (PRWEB) , ... June 29, 2015 , ... ... and imprinted accessories, is offering discounted pricing on all purchases that include branding. ... foundation of a brand is the logo. The website, packaging and promotional materials, all ...
(Date:6/29/2015)... VA (PRWEB) , ... June 29, 2015 , ... ... services to government contractors, nonprofits, independent schools, and other growing businesses across the ... Insights Top 100 Value Added Resellers for the fifth consecutive year. , Based ...
(Date:6/29/2015)... ... June 29, 2015 , ... Human Factors and Usability Studies: ... 2015 — 1:30 p.m. – 3:00 p.m. EDT, http://www.fdanews.com/humanfactors , The ... to the design of new products as well as to postmarket surveillance of ...
(Date:6/29/2015)... , ... June 29, 2015 , ... People across the country give their coworkers and ... part of our culture. , But, how often do coworkers donate “life” to the ... a simple one. , “Dawna (Wright-Thompson) told me her husband was on a ...
(Date:6/29/2015)... ... June 29, 2015 , ... Two ... against C.R. Bard, Inc. and Ethicon, Inc. continue to move forward in New ... Management Conference is to be convened on Thursday, July 23rd at 12:00 p.m. ...
Breaking Medicine News(10 mins):Health News:Stock Up on Logo Branding Tools Reduced this Month and Next Month from Displays and Exhibits 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 3Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 2Health News:FDAnews Announces Human Factors and Usability Studies: Understanding and Optimizing Interaction with Medical Devices Webinar, July 16, 2015 3Health News:VA Pittsburgh Employee Donates Kidney to Coworker’s Spouse 2Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 2Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 3Health News:Transvaginal Mesh Lawsuit News: New Jersey Court Overseeing Thousands of Ethicon, C.R. Bard Pelvic Mesh Claims Schedules July Conference 4
(Date:6/29/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a developer ... is now included in the Russell 3000®, the Russell ... to the indexes occurred at the close of trading ... its comprehensive set of U.S. and global indexes. ... Cap and Global Indexes coincides with the progress we ...
(Date:6/29/2015)... , June 29, 2015  Relmada Therapeutics, ... therapies for the treatment of chronic pain, announced ... study with novel formulations of oral, enteric-coated buprenorphine ... chronic pain and opioid dependence indications has reached ... company anticipates reporting top-line results in the second ...
(Date:6/29/2015)... England , June 29, 2015  Eli ... Immunocore Limited today announced that they have entered ... the utility of Immunocore,s lead T cell receptor-based ... (LY2157299) and merestinib (LY2801653) for the treatment of ... identify combination regimens that provide synergies in efficacy ...
Breaking Medicine Technology:Trovagene Upgraded to Russell 3000, Small Cap and Global Indexes 2Trovagene Upgraded to Russell 3000, Small Cap and Global Indexes 3Enrollment in Relmada Therapeutics' Proof-of-Concept Clinical Study for Novel Oral Formulations of Buprenorphine Reaches Halfway Mark 2Enrollment in Relmada Therapeutics' Proof-of-Concept Clinical Study for Novel Oral Formulations of Buprenorphine Reaches Halfway Mark 3Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 2Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 3Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 4Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 5Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 6Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma 7
Cached News: